Kelyniam Global, Inc. operates as a medical device manufacturing company, which engages in the production of custom prosthetics utilizing computer aided design and computer aided manufacturing of advanced medical grade polymers. The company is headquartered in Little Rock, Arkansas. The company went IPO on 2008-04-03. The firm is engaged in the production of custom prosthetics utilizing computer-aided design and computer-aided manufacturing of medical-grade polymers. Its Engineering Division uses Bio-Computer Aided Design (CAD) Computer Aided Manufacturing (CAM) technology to provide replicated cranial implants to replace damaged bone structures. Its product, PEEK-Optima, is engineered for biocompatibility. Derived from the patient’s computed tomography (CT) data, its 3D BIO-CAD/CAM software is used to transfer the details found on the edge of the defect directly to the implant edge. Its emergency plan, ke24, provides precision-replicated, patient-specific cranial implants in approximately 24 hours. The company distributes its products throughout the United States via independent distributors and sales representatives.
Follow-Up Questions
What is Kelyniam Global Inc (KLYG)'s P/E Ratio?
The P/E ratio of Kelyniam Global Inc is N/A
What is the price performance of KLYG stock?
The current price of KLYG is 0.066, it has decreased 0% in the last trading day.
What is Kelyniam Global Inc market cap?
Kelyniam Global Inc's current market cap is $3.2
Is Kelyniam Global Inc a buy, sell, or hold?
According to wall street analysts, 0 analysts have made analyst ratings for Kelyniam Global Inc, including 0 strong buy, 0 buy, 0 hold, 0 sell, and 0 strong sell
